surmount 5 tirzepatide SURMOUNT-5: and semaglutide go head-to-head in battle of weight loss drugs ECO 2026: SURMOUNT-MAINTAIN proves tirzepatide

The supplier company is located in Shanghai, Shanghai, and is one of the leading sellers of listed products

Last year, the US government negotiated price cuts that ranged from 38% to 79% for 10 highly popular prescription drugs used by Medicare, which will be effective in 2026

Adverse events in relation to GLP-1R agonists for the treatment of obesity are mainly gastrointestinal side effects, including nausea, diarrhoea, vomiting and constipation, which is consistent with observations in type 2 diabetes, and rates of discontinuation due to adverse events are generally higher with GLP-1R agonists treatment compared with placebo [26, 30,31,32,33,34,35,36,37,38,39]

A diverse high-fibre plant-based dietary intervention improves gut microbiome composition, gut symptoms, energy and hunger in healthy adults: a randomised controlled trial